ArticleBone & joint open2026
Patient-specific Ti-6Al-4V lattice implants for critical-sized, weightbearing limb reconstruction: average 45-month surgical, oncological, and functional follow-up.
Article in Bone & joint open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Patient-specific Ti-6Al-4V lattice implants present a new era for reconstruction of weightbearing segmental defects; however, robust clinical data from larger cohorts with longer follow-up remain limited. Building on our previous study that detailed the engineering, design, and surgical workflow of these implants, this study focuses on clinical outcomes. Specifically, we aimed to: 1) characterize surgical complications and limb-salvage rates; 2) report resection margins and oncological status at the latest follow-up; and 3) describe functional outcomes. Methods: This retrospective single-centre study includes 29 patients treated between January 2016 and December 2024 with long-bone tumour resection (n = 28) or post-traumatic nonunion (n = 1) of the femur or tibia. Resections were guided by intraoperative 3D-printed osteotomy patient-specific instruments followed by reconstruction with customized Ti-6Al-4V lattice implants. Minimum follow-up was 12 months. Surgical complications, reoperations, resection margins, metastasis, and local recurrence were recorded. Musculoskeletal Tumor Society (MSTS) scores were obtained at latest follow-up. Results: The mean age was 26.2 years (SD 18.0); anatomical sites were tibia (15/29, 52%) and femur (14/29, 48%). Early complications occurred in 3/29 (10.3%; one haematoma, two deep infections); late complications occurred in 4/29 (13.7%; one deep infection requiring staged revision with implant removal and fibular grafting, one mechanical failure revised to a megaprosthesis at four months, one subtalar fusion for symptomatic nonunion, and one component loosening and subluxation). Limb salvage was achieved in 27/29 patients (93.1%). At latest follow-up, 23 patients were with no evidence of disease, two alive with evidence of disease, and three dead of disease; metastasis occurred in seven patients and local recurrence in four patients. The median MSTS at latest follow-up was 80% (IQR 60% to 87%). Conclusion: In this heterogeneous cohort, patient-specific Ti-6Al-4V lattice implants achieved reliable reconstruction with acceptable complication rates, high limb salvage, and oncological control, with high functional outcomes, supporting this approach as a practical and effective solution for critical-sized, weightbearing defects reconstruction.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.